Thanks, BJ. I replied to your SI post on Tofacitinib asking if you stood by the comments in #msg-75285451. (I had presumed that you posted #msg-75285451 after at least scanning the FDA briefing docs.) If you don’t mind, please respond here so that we may keep this Tofacitinib thread untangled :- )
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”